Medical Research MCP Suite

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

No annotations are provided, so the description carries the full burden of behavioral disclosure. It mentions 'detailed market and competitive analysis', implying a read-only research operation, but doesn't describe what the analysis includes (e.g., market size, trends, competitor drugs), how results are formatted, whether it's a summary or raw data, or any limitations like rate limits or authentication needs. This leaves significant gaps for a tool with 5 parameters and no output schema.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is a single, efficient sentence that front-loads the core purpose without unnecessary words. It directly states what the tool does, making it easy to parse and understand quickly, with no wasted information.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Given the tool's complexity (5 parameters, no annotations, no output schema, and multiple siblings), the description is incomplete. It lacks behavioral details (e.g., output format, limitations), usage guidelines relative to siblings, and doesn't compensate for the absence of annotations or output schema, leaving the agent with insufficient context for effective use.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema description coverage is 100%, so the schema already documents all 5 parameters with descriptions. The description adds no additional meaning beyond implying analysis scope ('market and competitive'), which aligns with parameters like 'includeCompetitors' and 'marketScope' but doesn't provide extra syntax, format details, or usage context. This meets the baseline of 3 when schema coverage is high.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly states the tool's purpose as 'Detailed market and competitive analysis for specific drug/condition', which specifies the verb ('analysis') and resource ('market and competitive' for drug/condition). It distinguishes from some siblings like 'research_clinical_details' or 'research_safety_details' by focusing on market aspects, though it doesn't explicitly differentiate from 'research_competitive_landscape' or 'research_comprehensive_analysis'.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description provides no guidance on when to use this tool versus alternatives. It doesn't mention when to choose it over siblings like 'research_competitive_landscape' (which might focus only on competitors) or 'research_comprehensive_analysis' (which might be broader), nor does it specify any prerequisites or exclusions for usage.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.